Mr. Marino has been a director of Celldex since March 2017. Mr. Marino has served as a member of the board of directions of Onconova Therapeutics, Inc., a publicly held biopharmaceutical company, since July 2015 and currently serves as Chairman of the Board. Prior to July 2015, Mr. Marino was a partner at the global law firm Dechert LLP for 28 years, where he served as Managing Partner of the Princeton, N.J. office. His practice encompassed the representation of biotechnology companies in public and private financings, mergers and acquisitions, and strategic alliances. Previously he served on the Board of Directors of Pharmacopeia, Inc. He was a co-founder of BioNJ, a trade association of biotechnology companies based in New Jersey, and served as its counsel. Mr. Marino has worked in advisory capacities and on the boards of many non-profit organizations, including Robert Wood Johnson University Hospital, Wake Forest University Baptist Medical Center and Wake Forest University where he serves as a Life Trustee. Mr. Marino received his B.A., M.B.A. and his J.D. from Rutgers University.